Series
ELSI Friday Forum 2021
Ethical Challenges in Novel Gene Therapies for Sickle Cell Disease
Type
Webinar
ELSI Friday Forum • June 11, 2021
Pilar Ossorio, JD, PhD, moderates this session with panelists Liza-Marie Johnson, MD, MPH, MSB, and Melissa Creary, PhD, MPH, describing the current state of therapy for sickle cell disease, and some ethical issues that arise in the emerging use of gene transfer or gene editing for treating the disease. Dr. Johnson focuses on ethical issues identified by patients, and Dr. Creary discusses some of the social and historical ethical challenges that relate to genetic interventions for sickle cell.
Please see the attached transcript and resources files (located in the upper right-hand corner of the page) for more information.
Tags
Keywords
sickle cell disease
Gene Therapy / Gene Transfer
Genetic Intervention
Gene Transfer
Transcript File
Videos in Series
-
ELSI Friday Forum 2021 - New ACMG Guidance on Carrier Screening: More or Less Equitable?
-
ELSI Friday Forum 2021 - Benefit-sharing and Pharmaceutical Development in Africa: What Does Equity Mean?
-
ELSI Friday Forum 2021 - Genomic Data Sharing: Putting Principles and Policy into Practice
-
ELSI Friday Forum 2021 - Remembering 9/11: Ethical, Legal and Social Issues with Using DNA for Disaster Victim Identification
-
ELSI Friday Forum 2021 - Current Legal Challenges to Abortion: Implications for Prenatal Genetics
-
ELSI Friday Forum 2021 - Widening the Lens: Using Arts in ELSI Research
-
ELSI Friday Forum 2021 - Migrant DNA: Context, Ethics and Legal Issues
-
ELSI Friday Forum 2021 - Genomics and Infectious Disease: Scientific and ELSI Issues of COVID
-
ELSI Friday Forum 2021 - ELSI Friday Forum: Biobanking in the Era of COVID